The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: November 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next

Sanchez-Aguilera, A., Masmudi-Martín, M. et al. Cancer Cell. 41 (9): 1637-1649.E11 (2023).
doi: doi.org/10.1016/j.ccell.2023.07.010.

Summary of the findings

Brain metastases represent a major source of morbidity in cancer patients, with dramatic effect in their quality of life. These people exhibit a cognitive impairment that have been traditionally thought to result from the mass effect of the tumor growth. In this paper, the authors challenge this view and show that different experimental models of brain metastasis co-opt the function of the nearby neuronal circuits in vivo in a very specific manner. They recorded the intracranial electrical activity surrounding different brain metastasis types from various primary sources and oncogenomic profiles, and found characteristic features in the local field potential (LFP). These alterations were associated to changes in the density of GABAergic inhibitory synapses, calcium activity and specific transcriptional programs. For instance, they identified deregulation of the transcription factor Egr1 with roles in synaptic plasticity and angiogenesis, as a potential link with changes in electrical activity. Using data science and machine learning strategies, the authors show that a model trained in LFP signatures surrounding the three different brain metastasis can help to disambiguate between subtypes when confronted with recordings from a different metastatic line, and to anticipate brain metastases early in advance.
Figure legend. Three brain metastatic cell lines were inoculated in the same area of the brain where they generated tumors of the same size : E0771-BrM, a breast cancer brain metastatic cell line (green); B16/F10-BrM, a melanoma brain metastatic cell line (red); and 482N1, a lung cancer brain metastatic cell line, (blue). Mice with brain metastases were evaluated with electrophysiology (local field potential, LFP) to determine the impact of the tumor on brain activity in vivo. The LFP profiles clearly reflected heterogeneity on the impact of each brain metastasis model on neural activity, being the 482N1 the model generating the highest impact on neuronal communication. The computational analysis of the electrophysiological profiles allowed identifying the Principal Components that defined the heterogeneity in the electrophysiological patterns. This information was further exploited with artificial intelligence (e.g., Decision Trees) to prove the value of brain activity as a biomarker to define whether in a brain there is a metastasis and even the subtype of metastases. In our ongoing search to define the underlying cellular and molecular causes of the differential impact on neural circuits independent on the tumor mass effect we have found that the 482N1 model specifically decrease peritumoral inhibitory synapses (iSinapsis) and calcium activity. In addition we identified 51 genes specifically upregulated in the 482N1 model, including the transcription factor Egr1. Ctx: cerebral cortex; Hippo: hippocampus; Met: metastasis.

Future impact

This work opens the field to investigate the functional fingerprints of the crosstalk between cancer cells and the surrounding neuronal circuit as a potential translational biomarker. The concepts and potential mechanisms that are shown in this work advocate for considering a systematic cognitive assessment and electroencephalographic characterization of patients with brain metastases to advance artificial intelligence application for improved diagnostic tools. In addition, the possibility that a molecular mechanism underlies the impact of brain metastases on neuronal communication also offers the opportunity to develop a new therapeutic strategy aimed to improve the quality of life of these patients.

Read more in Cancer Cell

6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

How the EACR Congress inspired translational innovation and the launch of a spin-out company

How the EACR Congress inspired translational innovation and the launch of a spin-out company

May 14, 2026

EACR member Munitta Muthana provides some insight into her team’s experience at EACR 2025 in Lisbon, and how it catalysed the momentum and vision for their...

How Nerves Shape Cancer: From Energy Rewiring to Metastasis – Episode 32 of The Cancer Researcher Podcast

How Nerves Shape Cancer: From Energy Rewiring to Metastasis – Episode 32 of The Cancer Researcher Podcast

May 11, 2026

In recent years, the neuronal component of the cancer microenvironment and the metabolic plasticity of cancer cells have become increasingly recognised as essential for cancer progression....

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: April 2026

April 28, 2026

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

How the EACR Congress inspired translational innovation and the launch of a spin-out company
Career

How the EACR Congress inspired translational innovation and the launch of a spin-out company

May 14, 2026
“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship
Community

“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship

May 12, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR